The U.S. Senate unanimously passed a bill Thursday to help reduce the backlog of untested rape kits.
Texas Republican Sen. John Cornyn and California Democratic Sen. Dianne Feinstein introduced the “Debbie Smith Act of 2019,” which would reauthorize the Debbie Smith Act and give more resources to state and local law enforcement agencies to perform forensic analyses of crime scenes and untested rape kits.
The bipartisan legislation passed after a number of both Democratic and Republican lawmakers co-sponsored the bill.
“The Debbie Smith Act has long been an important tool in the fight to end the backlogs of untested kits in cities across America,” Cornyn said in a statement Friday. “I’m grateful to my Senate colleagues for recognizing the importance of this legislation to law enforcement seeking justice, survivors looking for answers, and families searching for closure.”
There is a related bill that New York Democratic Rep. Carolyn Maloney and Missouri GOP Rep. Ann Wagner introduced in the House.
“The Debbie Smith DNA Backlog Grant program has dramatically reduced the backlog of untested DNA rape kits, providing justice for rape survivors and getting dangerous predators off the streets. Since 2004, more than 860,000 rape kits have been tested and 360,000 DNA profiles uploaded to the FBI’s database thanks to this program,” Feinstein said in a statement Friday. “I’m glad the Senate remains committed to reducing the untested rape kit backlog and I look forward to continuing to work with my colleagues to get it reauthorized.” (RELATED: Old Rape Kits Got Tested, And Now A Lot Of Rapists Are In Jail)
Testing old rape kits has led to 165 prosecutions since 2015, including in rape-murder cases, The New York Times reported in March.
Follow Henry Rodgers On Twitter
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact email@example.com.